Publications - 2009
Results / Résultats : 32
Update / Mise à jour : 16/11/2010 - BioDoc
Amaral A I, Pacheco I, Teixeira A P, Deglon N, Bonvento G, Alves P M. (2009).
EFFECT OF THE DOWN-REGULATION OF GLUTAMATE TRANSPORTERS GLAST AND GLT-1 IN ASTROCYTIC METABOLIC FLUXES: DEPICTING METABOLIC ALTERATIONS IN HUNTINGTON'S DISEASE. Glia. 57: S105-S105. IF:04,932 [I2BM/Mircen]
Baligand C, Vauchez K, Fiszman M, Vilquin JT, Carlier PG. (2009).
Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs. Gene Ther. 16: 734-745. IF:04,745 [I2BM/Mircen] Lien vers le web
Bernay B, Gaillard MC, Guryca V, Emadali A, Kuhn L, Bertrand A, Detraz I, Carcenac C, Savasta M, Brouillet E, Garin J, Elalouf JM. (2009).
Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics. Mol Cell Proteomics. 08: 946-958. IF:08,791 [iBiTec-S/SBIGeMI2BM/Mircen] Lien vers le web
Cesaro P, Fenelon G, Remy P. (2009).
[Biotherapies and Parkinson's disease.] Rev Neurol (Paris). 165: 857-62. IF:00,605 [I2BM/Mircen] Lien vers le web
Chaumeil MM, Valette J, Guillermier M, Brouillet E, Boumezbeur F, Herard AS, Bloch G, Hantraye P, Lebon,V. (2009).
Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating P-31 MRS for measuring brain ATP synthesis Proc Natl Acad Sci U S A. 106: 3988-3993. IF:09,432 [I2BM/Mircen] Lien vers le web
Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P, Deglon N, Schwartz B, Barkats M, Heard J M, Tardieu M, Moullier P, Colle M A. (2009).
Human alpha-Iduronidase Gene Transfer Mediated by Adeno-Associated Virus Types 1, 2, and 5 in the Brain of Nonhuman Primates: Vector Diffusion and Biodistribution. Hum Gene Ther. 20: 350-360. IF:04,202 [I2BM/Mircen] Lien vers le web
Cleren C, Calingasan NY, Starkov A, Jacquard C, Chen J, Brouillet E, Beal MF. (2009).
Promethazine Protects Against 3-Nitropropionic Acid-induced Neurotoxicity. Neurochem Int. 56: 208-212. IF:03,541 [I2BM/Mircen] Lien vers le web
Colin A, Faideau M, Dufour N, Auregan G, Hassig R, Andrieu T, Brouillet E, Hantraye P, Bonvento G, Deglon N. (2009).
Engineered lentiviral vector targeting astrocytes In vivo. Glia. 57: 667-679. IF:04,932 [I2BM/Mircen] Lien vers le web
Dhenain M, El Tannir El Tayara N, Wu TD, Guégan M, Volk A, Quintana C, Delatour B. (2009).
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiol Aging. 30: 41-53. IF:05,937 [I2BM/Mircen] Lien vers le web
Diguet E, Petit F, Escartin C, Cambon K, Bizat N, Dufour N, Hantraye P, Déglon N, Brouillet E. (2009).
Normal aging modulates the neurotoxicity of mutant huntingtin. PLoS ONE. 4: e4637. IF:04,351 [I2BM/Mircen] Lien vers le web
Dolle F, Boutin H, Thominiaux C, Chauveau F, Boisgard R, Demphel S, Roy S, Boisnard S, Rooney T, Benavides J, Hantraye P, Tavitian B. (2009).
CARBON-11 LABELING AND PRELIMINARY EVALUATION OF SSR180575, A HIGHLY PROMISING RADIOLIGAND FOR IMAGING THE PERIPHERAL BENZODIAZEPINE RECEPTOR WITH PET. J Label Compd Radiopharm. 52: S93-S93. IF:00,689 [I2BM/SHFJI2BM/Mircen]
Dolle F, Boisgard R, Damont A, Van Camp N, Kuhnast B, Chauveau F, Boutin H, Hantraye P, Tavitian B. (2009).
IMAGING NEUROINFLAMMATION WITH POSITRON EMISSION TOMOGRAPHY: THE QUEST FOR PROBES TARGETING THE TRANSLOCATOR PROTEIN IS KDA. Glia. 57: S125-S125. IF:04,932 [I2BM/SHFJI2BM/Mircen]
Dolle F, Boutin H, Chauveau F, Thominiaux C, Van Camp N, Roy S, Boisnard S, Rooney T, Benavides J, Hantraye P, Boisgard R, Tavitian B. (2009).
[11C]SSR180575, A PROMISING POSITRON EMISSION TOMOGRAPHY RADIOLIGAND FOR IMAGING THE PERIPHERAL BENZODIAZEPINE RECEPTOR. Glia. 57: S137-S137. IF:04,932 [I2BM/SHFJI2BM/Mircen]
Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Deglon N. (2009).
Sustained Effects of Nonallele-Specific Huntingtin Silencing. Ann Neurol. 65: 276-285. IF:09,317 [I2BM/Mircen] Lien vers le web
Drouet V, Hassig R, Auregan G, Dufour N, Gorrichon K, Brouillet E, Bonvento G, Hantraye P, Deglon N. (2009).
Allele-Specific Silencing of Mutant Huntingtin in a Lentiviral-Based Rat Model of Huntington's Disease. Mol Ther. 17: S194-S195. IF:06,239 [I2BM/Mircen]
Dufour S, Lebon V, Shulman GI, Petersen KF. (2009).
Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans. AM J PHYSIOL-ENDOC M. 297: E231-5. IF:04,395 [I2BM/Mircen] Lien vers le web
Giaume C, Maravall M, Welker E, Bonvento G. (2009).
The Barrel Cortex as a Model to Study Dynamic Neuroglial Interaction Neuroscientist. 15: 351-366. IF:06,079 [I2BM/Mircen] Lien vers le web
Hantraye P. (2009).
Imaging and translational research : neurodegenerative diseases. Bull Acad Natl Med. 193: 863-867. IF:00,407 [I2BM/Mircen]
Jarraya B, Boulet S, Ralph G S, Jan C, Bonvento G, Azzouz M, Miskin J E, Shin M, Delzescaux T, Drouot X, Herard A S, Day D M, Brouillet E, Kingsman S M, Hantraye P, Mitrophanous K A, Mazarakis N D, Palfi S. (2009).
Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia. Sci Transl Med. 1: 11. IF:non répertorié [I2BM/Mircen] Lien vers le web
Jarraya B, Ralph S, Lepetit H, Stratful E, Boulet S, Jan C, Bonvento G, Azzouz M, Miskin J E, Gurruchaga J M, Vinti M, Fenelon G, Brugiere P, Remy P, Kingsman S M, Hantraye P, Mitrophanous K A, Mazarakis N D, Palfi S. (2009).
A Phase I/II Trial for Parkinson's Disease Using a Lentiviral Vector (ProSavin (R)). Mol Ther. 17: S197-S197. IF:06,239 [I2BM/Mircen]
Kas A, Bottlaender M, Gallezot JD, Vidailhet M, Villafane G, Grégoire MC, Coulon C, Valette H, Dollé F, Ribeiro MJ, Hantraye P, Remy P. (2009).
Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. J CEREBR BLOOD F MET. 29: 1601-1608. IF:05,457 [I2BM/Mircen] Lien vers le web
Kraska A, Dorieux O, Picq JL, Petit F, Bourrin E, Chenu E, Volk A, Perret M, Hantraye P, Mestre-Frances N, Aujard F, Dhenain M. (2009).
Age-associated cerebral atrophy in mouse lemur primates. Neurobiol Aging. in print: IF:05,937 [I2BM/MircenI2BM/Neurospin] Lien vers le web
Leriche L, Björklund T, Breysse N, Besret L, Grégoire MC, Carlsson T, Dollé F, Mandel RJ, Déglon N, Hantraye P, Kirik D. (2009).
Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy. J Neurosci. 29: 1544-53. IF:07,178 [I2BM/MircenI2BM/SHFJ] Lien vers le web
Martin C, Houitte D, Guillermier M, Roux L, Giaume C, Bonvento G, Gurden H. (2009).
METABOLIC REGULATION AND NEURONAL OSCILLATIONS IN THE OLFACTORY BULB ARE UNDER THE INFLUENCE OF ASTROCYTIC NETWORKS. Glia. 57: S41-S41. IF:04,932 [I2BM/Mircen]
Nagasawa K, Escartin C, Swanson RA. (2009).
Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands. Glia. 57: 622-633. IF:04,932 [I2BM/Mircen] Lien vers le web
Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, Yelnik J, Samson Y, Rascol O, Agid Y, Damier P. (2009).
Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. J Cereb Blood Flow Metab. 29: 235-243. IF:05,457 [I2BM/SHFJI2BM/Mircen] Lien vers le web
Rudinskiy N, Kaneko Y A, Beesen A A, Gokce O, Regulier E, Deglon N, Luthi-Carter R. (2009).
Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. J Neurochem. 111: 460-472. IF:03,999 [I2BM/Mircen] Lien vers le web
Shin M, Jan C, Jacquard C, Jaraya B, Callebert J, Launay JM, Hantraye P, Remy P, Palfi S, Brouillet E. (2009).
Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiol Aging. in print: IF:05,937 [I2BM/Mircen] Lien vers le web
Thomsen K, Piilgaard H, Gjedde A, Bonvento G, Lauritzen M. (2009).
Principal cell spiking, postsynaptic excitation, and oxygen consumption in the rat cerebellar cortex. J Neurophysiol. 102: 1503-1512. IF:03,483 [I2BM/Mircen] Lien vers le web
Trocello JM, Chappuis P, Chaine P, Rémy P, Debray D, Duclos-Vallée JC, Woimant F. (2009).
Wilson disease. Presse Med. 38: 1089-1098. IF:00,416 [I2BM/Mircen] Lien vers le web
Valette J, Boumezbeur F, Hantraye P, Lebon V. (2009).
Simplified C-13 Metabolic Modeling for Simplified Measurements of Cerebral TCA Cycle Rate In Vivo. Magn Reson Med. 62: 1641-1645. IF:03,225 [I2BM/MircenI2BM/Neurospin] Lien vers le web
Zanotti-Fregonara P, Fadaili E M, Maroy R, Comtat C, Souloumiac A, Jan S, Ribeiro M J, Gaura V, Bar-Hen A, Trebossen R. (2009).
Comparison of eight methods for the estimation of the image-derived input function in dynamic [F-18]-FDG PET human brain studies. J Cereb Blood Flow Metab. 29: 1825-1835. IF:05,457 [I2BM/SHFJI2BM/Mircen] Lien vers le web